Neurogene Inc. Foreign Currency Transaction Gain (Loss), before Tax
Neurogene Inc. (NGNE) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2022-03-01
- Neurogene Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2020-03-31 was $15.00K, a 650.00% increase year-over-year.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-12-31 was -$10.00K.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-09-30 was $1.00K.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-06-30 was -$9.00K.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for fiscal 2021 was -$1.00K, a 120.00% decline from fiscal 2020.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for fiscal 2020 was $5.00K.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for fiscal 2019 was -$16.00K.
- Neurogene Inc. foreign currency transaction gain (loss), before tax for fiscal 2018 was -$75.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 123 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$1.00K 10-K · filed 2022-03-01 | ||||
| 2020-12-31 | $5.00K 10-K · filed 2022-03-01 | ||||
| 2020-03-31 | $15.00K 10-Q · filed 2020-05-06 | $5.00K derived: sum of 2 quarters · filed 2021-03-25 | $6.00K derived: sum of 3 quarters · filed 2021-03-25 | -$3.00K derived: sum of 4 quarters · filed 2021-03-25 | |
| 2019-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$9.00K derived: sum of 2 quarters · filed 2021-03-25 | -$18.00K derived: sum of 3 quarters · filed 2021-03-25 | -$16.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-13 | -$8.00K derived: sum of 2 quarters · filed 2019-11-13 | -$6.00K 10-Q · filed 2019-11-13 | -$47.00K derived: sum of 4 quarters · filed 2020-05-06 | |
| 2019-06-30 | -$9.00K 10-Q · filed 2019-08-01 | -$7.00K 10-Q · filed 2019-08-01 | -$48.00K derived: sum of 3 quarters · filed 2020-05-06 | -$51.00K derived: sum of 4 quarters · filed 2020-05-06 | |
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-06 | -$39.00K derived: sum of 2 quarters · filed 2020-05-06 | -$42.00K derived: sum of 3 quarters · filed 2020-05-06 | -$72.00K derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$44.00K derived: sum of 2 quarters · filed 2020-03-12 | -$74.00K derived: sum of 3 quarters · filed 2020-03-12 | -$75.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$3.00K 10-Q · filed 2019-11-13 | -$33.00K derived: sum of 2 quarters · filed 2019-11-13 | -$34.00K 10-Q · filed 2019-11-13 | -$41.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | -$30.00K 10-Q · filed 2019-08-01 | -$31.00K 10-Q · filed 2019-08-01 | -$38.00K derived: sum of 3 quarters · filed 2020-03-12 | -$30.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | -$1.00K 10-Q · filed 2019-05-07 | -$8.00K derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | -$12.00K derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.00K derived: sum of 2 quarters · filed 2020-03-12 | -$11.00K derived: sum of 3 quarters · filed 2020-03-12 | -$19.00K 10-K · filed 2020-03-12 | |
| 2017-09-30 | $8.00K 10-Q · filed 2018-11-07 | -$4.00K derived: sum of 2 quarters · filed 2018-11-07 | -$12.00K 10-Q · filed 2018-11-07 | -$4.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-06-30 | -$12.00K 10-Q · filed 2018-08-08 | -$20.00K 10-Q · filed 2018-08-08 | -$12.00K derived: sum of 3 quarters · filed 2019-03-07 | -$13.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-03-31 | -$8.00K 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | -$1.00K derived: sum of 3 quarters · filed 2019-03-07 | $5.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2016-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $7.00K derived: sum of 2 quarters · filed 2019-03-07 | $13.00K derived: sum of 3 quarters · filed 2019-03-07 | -$13.00K 10-K · filed 2019-03-07 | |
| 2016-09-30 | -$1.00K 10-Q · filed 2017-11-08 | $5.00K derived: sum of 2 quarters · filed 2017-11-08 | -$21.00K 10-Q · filed 2017-11-08 | -$92.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $6.00K 10-Q · filed 2017-08-08 | -$20.00K 10-Q · filed 2017-08-08 | -$91.00K derived: sum of 3 quarters · filed 2018-03-12 | -$139.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | -$26.00K 10-Q · filed 2017-05-09 | -$97.00K derived: sum of 2 quarters · filed 2018-03-12 | -$145.00K derived: sum of 3 quarters · filed 2018-03-12 | -$124.00K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$119.00K derived: sum of 2 quarters · filed 2018-03-12 | -$98.00K derived: sum of 3 quarters · filed 2018-03-12 | -$476.00K 10-K · filed 2018-03-12 | |
| 2015-09-30 | -$48.00K 10-Q · filed 2016-11-09 | -$27.00K derived: sum of 2 quarters · filed 2016-11-09 | -$405.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $21.00K 10-Q · filed 2016-08-04 | -$357.00K 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | -$361.00K 10-K · filed 2017-03-09 | ||||
| 2014-03-31 | -$192.06K 10-Q · filed 2014-05-13 | -$239.48K 10-Q · filed 2014-05-13 | |||
| 2013-03-31 | -$17.00K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |